Literature DB >> 27225277

Drug resistant focal epilepsy in a patient with myotonic dystrophy type 2: casual or causal association?

L Giuliano1, V Sofia1, R Cardani2, G Meola2, M Zappia3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27225277     DOI： 10.1007/s10072-016-2619-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Cerebral and muscle MRI abnormalities in myotonic dystrophy.

Authors:  Daniel T Franc; Ryan L Muetzel; Paul R Robinson; Craig P Rodriguez; Joline C Dalton; Cameron E Naughton; Bryon A Mueller; Jeffrey R Wozniak; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2012-01-30       Impact factor: 4.296

2.  Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.

Authors:  R Cardani; E Mancinelli; V Sansone; G Rotondo; G Meola
Journal:  Eur J Histochem       Date:  2004 Oct-Dec       Impact factor: 3.188

3.  Consensus on cerebral involvement in myotonic dystrophy: workshop report: May 24-27, 2013, Ferrere (AT), Italy.

Authors:  E Bugiardini; G Meola
Journal:  Neuromuscul Disord       Date:  2014-02-07       Impact factor: 4.296

4.  Generalized epilepsy in a patient with myotonic dystrophy type 2.

Authors:  C Cagnetti; L Buratti; N Foschi; S Balestrini; L Provinciali
Journal:  Neurol Sci       Date:  2013-11-26       Impact factor: 3.307

Review 5.  Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

Authors:  Giovanni Meola
Journal:  Acta Myol       Date:  2013-12
  5 in total
  1 in total

1.  Altered levels of the splicing factor muscleblind modifies cerebral cortical function in mouse models of myotonic dystrophy.

Authors:  Gang Chen; Russell E Carter; John D Cleary; Tammy S Reid; Laura P Ranum; Maurice S Swanson; Timothy J Ebner
Journal:  Neurobiol Dis       Date:  2018-01-10       Impact factor: 5.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.